Strides Pharma unit gets USFDA nod for generic drug to treat gastrointestinal diseases

Strides Pharma Science on Wednesday said its unit has received approval from the US health regulator to market a generic medication used in the treatment of gastrointestinal diseases. Singapore-based Strides Pharma Global Pte. Ltd, has received approval for the generic version of Sucralfate Oral Suspension, 1gm/10 mL, from the US Food & Drug Administration (USFDA), the drug firm said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LG5Nzko
via IFTTT